• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增强肺中树突状细胞介导的DNA疫苗接种的策略。

Strategy to enhance dendritic cell-mediated DNA vaccination in the lung.

作者信息

Kim Yoo C, Hsueh Henry T, Kim Namho, Rodriguez Jason, Leo Kirby T, Rao Divya, West Natalie E, Hanes Justin, Suk Jung Soo

机构信息

Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21231.

Department of Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD 21231.

出版信息

Adv Ther (Weinh). 2021 Feb;4(2). doi: 10.1002/adtp.202000228. Epub 2021 Feb 24.

DOI:10.1002/adtp.202000228
PMID:33709020
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7941873/
Abstract

We here introduce a new paradigm to promote pulmonary DNA vaccination. Specifically, we demonstrate that nanoparticles designed to rapidly penetrate airway mucus (mucus-penetrating particle or MPP) enhance the delivery of inhaled model DNA vaccine (i.e. ovalbumin-expressing plasmids) to pulmonary dendritic cells (DC), leading to robust and durable local and trans-mucosal immunity. In contrast, mucus-impermeable particles were poorly taken up by pulmonary DC following inhalation, despite their superior ability to mediate DC uptake compared to MPP. In addition to the enhanced immunity achieved in mucosal surfaces, inhaled MPP unexpectedly provided significantly greater systemic immune responses compared to gold-standard approaches applied in the clinic for systemic vaccination, including intradermal injection and intramuscular electroporation. We also showed here that inhaled MPP significantly enhanced the survival of an orthotopic mouse model of aggressive lung cancer compared to the gold-standard approaches. Importantly, we discovered that MPP-mediated pulmonary DNA vaccination induced memory T-cell immunity, particularly the ready-to-act effector memory-biased phenotype, both locally and systemically. The findings here underscore the importance of breaching the airway mucus barrier to facilitate DNA vaccine uptake by pulmonary DC and thus to initiate full-blown immune responses.

摘要

在此,我们引入一种促进肺部DNA疫苗接种的新范式。具体而言,我们证明了设计用于快速穿透气道黏液的纳米颗粒(黏液穿透颗粒或MPP)可增强吸入型模型DNA疫苗(即表达卵清蛋白的质粒)向肺部树突状细胞(DC)的递送,从而引发强大且持久的局部和跨黏膜免疫。相比之下,尽管与MPP相比,黏液不可渗透颗粒介导DC摄取的能力更强,但吸入后肺部DC对其摄取能力较差。除了在黏膜表面实现增强免疫外,与临床上用于全身疫苗接种的金标准方法(包括皮内注射和肌肉电穿孔)相比,吸入MPP意外地产生了显著更强的全身免疫反应。我们还在此表明,与金标准方法相比,吸入MPP显著提高了侵袭性肺癌原位小鼠模型的存活率。重要的是,我们发现MPP介导的肺部DNA疫苗接种在局部和全身均诱导了记忆性T细胞免疫,尤其是偏向于随时发挥作用的效应记忆表型。此处的研究结果强调了突破气道黏液屏障以促进肺部DC摄取DNA疫苗从而引发全面免疫反应的重要性。

相似文献

1
Strategy to enhance dendritic cell-mediated DNA vaccination in the lung.增强肺中树突状细胞介导的DNA疫苗接种的策略。
Adv Ther (Weinh). 2021 Feb;4(2). doi: 10.1002/adtp.202000228. Epub 2021 Feb 24.
2
Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier.通过能够穿透气道黏液屏障的纳米颗粒对黏液阻塞性肺病进行临床前吸入基因治疗。
Thorax. 2022 Aug;77(8):812-820. doi: 10.1136/thoraxjnl-2020-215185. Epub 2021 Oct 25.
3
Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation.吸入后,不附着在黏液上的纳米颗粒为气道提供均匀且持久的药物输送。
Sci Adv. 2017 Apr 5;3(4):e1601556. doi: 10.1126/sciadv.1601556. eCollection 2017 Apr.
4
Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis.用于高效肺部递送的动态黏液穿透微球,并增强宿主防御肽 (HDP) 在实验性结核病中的疗效。
J Control Release. 2020 Aug 10;324:17-33. doi: 10.1016/j.jconrel.2020.05.013. Epub 2020 May 11.
5
A short hairpin RNA-based adjuvant targeting NF-κB repressor IκBα promotes migration of dermal dendritic cells to draining lymph nodes and antitumor CTL responses induced by DNA vaccination.一种靶向核因子κB抑制因子IκBα的短发夹RNA佐剂可促进真皮树突状细胞向引流淋巴结的迁移以及DNA疫苗诱导的抗肿瘤细胞毒性T淋巴细胞反应。
Vaccine. 2017 Jul 24;35(33):4148-4154. doi: 10.1016/j.vaccine.2017.06.041. Epub 2017 Jun 27.
6
Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge.呼吸道黏膜接种肽-聚氧乙烯-二亚胺-DNA 纳米粒可提供针对致死性 SARS-CoV-2 挑战的完全保护。
Biomaterials. 2023 Jan;292:121907. doi: 10.1016/j.biomaterials.2022.121907. Epub 2022 Nov 18.
7
Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.比较皮内和肌内递送,然后对恒河猴进行 SIV Env DNA 的体内电穿孔。
Hum Vaccin Immunother. 2013 Oct;9(10):2081-94. doi: 10.4161/hv.25473. Epub 2013 Jun 28.
8
Enhanced pulmonary delivery of fluticasone propionate in rodents by mucus-penetrating nanoparticles.通过黏液穿透性纳米颗粒增强丙酸氟替卡松在啮齿动物肺部的递送。
Int J Pharm. 2016 Apr 11;502(1-2):188-97. doi: 10.1016/j.ijpharm.2016.02.031. Epub 2016 Feb 20.
9
Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.与肌肉注射和皮内基因枪递送相比,通过电穿孔接种人乳头瘤病毒(HPV)DNA疫苗可引发最强的CD8 + T细胞免疫反应。
Vaccine. 2009 Sep 4;27(40):5450-9. doi: 10.1016/j.vaccine.2009.07.005. Epub 2009 Jul 19.
10
Intranasal Vaccination with Mannosylated Chitosan Formulated DNA Vaccine Enables Robust IgA and Cellular Response Induction in the Lungs of Mice and Improves Protection against Pulmonary Mycobacterial Challenge.鼻腔内接种甘露糖化壳聚糖配方 DNA 疫苗可在小鼠肺部诱导强烈的 IgA 和细胞应答,并改善对肺部分枝杆菌挑战的保护。
Front Cell Infect Microbiol. 2017 Oct 16;7:445. doi: 10.3389/fcimb.2017.00445. eCollection 2017.

引用本文的文献

1
Pulmonary Delivery of Nonviral Nucleic Acid-Based Vaccines With Spotlight on Gold Nanoparticles.以金纳米颗粒为重点的非病毒核酸疫苗的肺部递送
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2025 Jan-Feb;17(1):e70000. doi: 10.1002/wnan.70000.
2
Pulmonary inhalation for disease treatment: Basic research and clinical translations.用于疾病治疗的肺部吸入:基础研究与临床转化
Mater Today Bio. 2024 Jan 22;25:100966. doi: 10.1016/j.mtbio.2024.100966. eCollection 2024 Apr.
3
Advanced approaches to overcome biological barriers in respiratory and systemic routes of administration for enhanced nucleic acid delivery to the lung.克服呼吸和全身给药途径中生物屏障的先进方法,以增强核酸递送至肺部的效果。
Expert Opin Drug Deliv. 2023 Jul-Dec;20(11):1531-1552. doi: 10.1080/17425247.2023.2282535. Epub 2023 Dec 20.
4
Perspectives on Multiscale Colloid-Based Materials for Biomedical Applications.用于生物医学应用的基于胶体的多尺度材料的展望
Langmuir. 2023 Oct 3;39(39):13759-13769. doi: 10.1021/acs.langmuir.3c01274. Epub 2023 Sep 21.
5
Inhaled drug delivery for the targeted treatment of asthma.吸入式药物输送在哮喘靶向治疗中的应用。
Adv Drug Deliv Rev. 2023 Jul;198:114858. doi: 10.1016/j.addr.2023.114858. Epub 2023 May 12.
6
Biomaterials for intranasal and inhaled vaccine delivery.用于鼻内和吸入式疫苗递送的生物材料。
Nat Rev Bioeng. 2023 Feb;1(2):83-84. doi: 10.1038/s44222-022-00012-6. Epub 2023 Jan 24.
7
Mucus-penetrating nonviral gene vaccine processed in the epithelium for inducing advanced vaginal mucosal immune responses.在上皮细胞中加工的穿透黏液的非病毒基因疫苗,用于诱导高级阴道黏膜免疫反应。
Acta Pharm Sin B. 2023 Mar;13(3):1287-1302. doi: 10.1016/j.apsb.2022.11.004. Epub 2022 Nov 4.
8
Respiratory mucosal vaccination of peptide-poloxamine-DNA nanoparticles provides complete protection against lethal SARS-CoV-2 challenge.呼吸道黏膜接种肽-聚氧乙烯-二亚胺-DNA 纳米粒可提供针对致死性 SARS-CoV-2 挑战的完全保护。
Biomaterials. 2023 Jan;292:121907. doi: 10.1016/j.biomaterials.2022.121907. Epub 2022 Nov 18.
9
Non-Cellular Layers of the Respiratory Tract: Protection against Pathogens and Target for Drug Delivery.呼吸道的非细胞层:抵御病原体及药物递送靶点
Pharmaceutics. 2022 May 5;14(5):992. doi: 10.3390/pharmaceutics14050992.
10
Inhaled gene therapy of preclinical muco-obstructive lung diseases by nanoparticles capable of breaching the airway mucus barrier.通过能够穿透气道黏液屏障的纳米颗粒对黏液阻塞性肺病进行临床前吸入基因治疗。
Thorax. 2022 Aug;77(8):812-820. doi: 10.1136/thoraxjnl-2020-215185. Epub 2021 Oct 25.

本文引用的文献

1
Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques.反复暴露于猕猴中的局部卡介苗预防结核感染和疾病。
Nat Med. 2019 Feb;25(2):255-262. doi: 10.1038/s41591-018-0319-9. Epub 2019 Jan 21.
2
Hypoxia-tropic Protein Nanocages for Modulation of Tumor- and Chemotherapy-Associated Hypoxia.缺氧靶向蛋白纳米笼用于调节肿瘤和化疗相关缺氧。
ACS Nano. 2019 Jan 22;13(1):236-247. doi: 10.1021/acsnano.8b05399. Epub 2018 Dec 26.
3
A Review of DNA Vaccines Against Influenza.抗流感DNA疫苗综述。
Front Immunol. 2018 Jul 9;9:1568. doi: 10.3389/fimmu.2018.01568. eCollection 2018.
4
Nanoparticles that do not adhere to mucus provide uniform and long-lasting drug delivery to airways following inhalation.吸入后,不附着在黏液上的纳米颗粒为气道提供均匀且持久的药物输送。
Sci Adv. 2017 Apr 5;3(4):e1601556. doi: 10.1126/sciadv.1601556. eCollection 2017 Apr.
5
The Mucus Barrier to Inhaled Gene Therapy.吸入式基因治疗的黏液屏障
Mol Ther. 2016 Dec;24(12):2043-2053. doi: 10.1038/mt.2016.182. Epub 2016 Sep 20.
6
Barriers to inhaled gene therapy of obstructive lung diseases: A review.阻塞性肺病吸入式基因治疗的障碍:综述
J Control Release. 2016 Oct 28;240:465-488. doi: 10.1016/j.jconrel.2016.05.031. Epub 2016 May 16.
7
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery.聚乙二醇化作为一种改善基于纳米颗粒的药物和基因递送的策略。
Adv Drug Deliv Rev. 2016 Apr 1;99(Pt A):28-51. doi: 10.1016/j.addr.2015.09.012. Epub 2015 Oct 9.
8
Highly compacted biodegradable DNA nanoparticles capable of overcoming the mucus barrier for inhaled lung gene therapy.高度致密的可生物降解DNA纳米颗粒,能够克服黏液屏障用于吸入式肺部基因治疗。
Proc Natl Acad Sci U S A. 2015 Jul 14;112(28):8720-5. doi: 10.1073/pnas.1502281112. Epub 2015 Jun 29.
9
Particle tracking in drug and gene delivery research: State-of-the-art applications and methods.药物与基因递送研究中的粒子追踪:最新应用与方法
Adv Drug Deliv Rev. 2015 Aug 30;91:70-91. doi: 10.1016/j.addr.2015.03.017. Epub 2015 Apr 7.
10
Fusion of ubiquitin to HIV gag impairs human monocyte-derived dendritic cell maturation and reduces ability to induce gag T cell responses.泛素与HIV gag融合会损害人单核细胞衍生的树突状细胞成熟,并降低诱导gag特异性T细胞反应的能力。
PLoS One. 2014 Feb 5;9(2):e88327. doi: 10.1371/journal.pone.0088327. eCollection 2014.